Deutsche Bank Adjusts Price Target on Verisk Analytics to $200 From $225

Deutsche Bank reduced its price target for Verisk Analytics from $225 to $200. The stock is currently trading at $176.68, up 0.68% on the day and down 21.55% over the year. Evercore ISI also adjusted its target to $223 from $222.

Original reporting
Published Oct 9, 2026, 11:58 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 1:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$VRSK
Bearish
high confidence
Mentioned
$VRSK
Relevance
6/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$VRSKBearishMed
01

Why it matters

The target reduction signals a bearish outlook, likely prompting short‑term selling pressure.

02

Market read

A fresh analyst downgrade for a US‑listed data‑analytics firm, offering a modest trading signal.

03

What to watch

Potential upcoming contract wins or regulatory changes could offset the downgrade.

Relevance 6/10Novelty 6/10Timing: pre-market today

Background

Analyst price‑target adjustments are common after earnings releases or new guidance; this article provides the latest target change from Deutsche Bank.

Company-level read

Ticker impact

$VRSKBearishHigh confidence
Context

Deutsche Bank lowered its price target for Verisk Analytics to $200 from $225, a new analyst rating disclosed today.

Expected impact

potential downside as investors price in the reduced target

Evidence & confidence

Analyst target cuts are a direct catalyst that often lead to short-term price declines.

Market effects

May weigh on the broader data analytics and risk management sector as peers could face similar valuation scrutiny.

Primarily affects US markets where VRSK trades; limited regional spillover.

Low global impact beyond investors tracking US data‑service stocks.

Counterpoint

Some investors may view the target cut as an overreaction if recent earnings beat expectations.

Key entities

  • Deutsche Bank

    Issuer of the new price target for Verisk Analytics.

  • Verisk Analytics

    Provider of data analytics and risk assessment services.

Related articles

$VRSKHighAI 8/10

RBC Capital reiterates Verisk Analytics stock rating at Outperform

RBC Capital reiterated an Outperform rating and $230 price target for Verisk Analytics (VRSK) after a court ruling on its AccuLynx acquisition. The Delaware Supreme Court ordered Verisk to pursue FTC approval and close the $2.35B deal, awarding AccuLynx costs. Verisk will comply, with the transaction subject to FTC review. The deal may constrain share buybacks and increase leverage. Verisk's Q2 earnings and revenue slightly beat estimates, and BMO Capital raised its price target to $248.

$VRSKMed

VRSK Maintained by Barclays -- Price Target Lowered to $225

Barclays maintained an Overweight rating on Verisk Analytics (VRSK) but lowered its price target from $275 to $225. The company's stock is trading at $179.17, which GuruFocus estimates is 44.4% undervalued. Verisk has a GF Score of 78/100, indicating strong profitability and growth, but lower momentum. Insider activity shows significant selling, with $2.55 million in sales over the past three months.

$VRSKMed

Is Verisk’s Q2 Beat, Buyback and AI Push Altering The Investment Case For Verisk Analytics (VRSK)?

Verisk Analytics (VRSK) reported Q2 2026 earnings and revenue above estimates, reaffirmed its 2026 outlook, and announced a $200M share repurchase. The company emphasized growth in AI and data analytics for insurance clients. Verisk projects $3.8B in revenue and $1.3B in earnings by 2029, with a 24% upside to its current price. The company's high debt levels and interest expenses remain key risks.

$VRSKMedAI 8/10

Verisk (VRSK) Down 4.7% Since Last Earnings Report: Can It Rebound?

Verisk (VRSK) shares fell 4.7% since its last earnings report. Q2 2026 earnings beat estimates at $1.98 per share, up 5.3% YoY. Revenue rose 4.3% to $806.3M. Underwriting and claims revenues increased 3.5% and 6.3% respectively. EBITDA grew 4.2% but net income declined 9.8% due to higher taxes and interest. The company maintained 2026 guidance and approved a dividend. Estimates have trended downward, with a Zacks Rank #3 (Hold).